Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma

作者: Jing Li , Meihua Wang , Minhee Won , Edward G. Shaw , Christopher Coughlin

DOI: 10.1016/J.IJROBP.2010.06.012

关键词: Explained variationAnaplastic astrocytomaMedicineMultivariate analysisRadiation therapyOncologyInternal medicineGliomaRecursive partitioningText miningPerformance status

摘要: Purpose Previous recursive partitioning analysis (RPA) of patients with malignant glioma (glioblastoma multiforme [GBM] and anaplastic astrocytoma [AA]) produced six prognostic groups (I–VI) classified by factors. We sought here to determine whether the classification for GBM could be improved using an updated Radiation Therapy Oncology Group (RTOG) database excluding AA considering additional baseline variables. Methods Materials The new considered 42 variables 1,672 from expanded RTOG database. Patients receiving radiation only were excluded such that all received radiation+carmustine. “Radiation dose received” was replaced “radiation assigned.” RPA models compared original model applying them a test dataset comprising 488 other trials. Fitness evaluated explained variation. Results more variations in survival than did (20% vs. 15%) therefore chosen further analysis. It reduced combining Classes V VI produce three classes (Classes III, IV, V+VI), as had indistinguishable dataset. simplified not improve performance (explained variation 18% 20%) but is easier apply because it involves four variables: age, status, extent resection, neurologic function. Applying this resulted distinct median times 17.1, 11.2, 7.5 months V+VI, respectively. Conclusions final model, VI, defined This will used future

参考文章(42)
R A Olshen, L Gordon, Tree-structured survival analysis. Cancer treatment reports. ,vol. 69, pp. 1065- 1069 ,(1985)
J. Del Rowe, C. Scott, M. Werner-Wasik, J.P. Bahary, W.J. Curran, R.C. Urtasun, B. Fisher, Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme Journal of Clinical Oncology. ,vol. 18, pp. 1254- 1259 ,(2000) , 10.1200/JCO.2000.18.6.1254
Edward L. Korn, Richard Simon, Measures of explained variation for survival data. Statistics in Medicine. ,vol. 9, pp. 487- 503 ,(1990) , 10.1002/SIM.4780090503
Corey J. Langer, James Ruffer, Harker Rhodes, Rebecca Paulus, Kevin Murray, Benjamin Movsas, Walter Curran, Phase II Radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme International Journal of Radiation Oncology Biology Physics. ,vol. 51, pp. 113- 119 ,(2001) , 10.1016/S0360-3016(01)01597-8
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
James Perry, Normand Laperriere, Lisa Zuraw, Alexandra Chambers, Karen Spithoff, J. Gregory Cairncross, Adjuvant chemotherapy for adults with malignant glioma: a systematic review. Canadian Journal of Neurological Sciences. ,vol. 34, pp. 402- 410 ,(2007) , 10.1017/S0317167100007265
Maria Werner-Wasik, Charles B. Scott, Diana F. Nelson, Laurie E. Gaspar, Kevin J. Murray, Jennifer A. Fischbach, James S. Nelson, Alan S. Weinstein, Walter J. Curran, Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02 Cancer. ,vol. 77, pp. 1535- 1543 ,(1996) , 10.1002/(SICI)1097-0142(19960415)77:8<1535::AID-CNCR17>3.0.CO;2-0
Patrick S. Ward, Jay Patel, David R. Wise, Omar Abdel-Wahab, Bryson D. Bennett, Hilary A. Coller, Justin R. Cross, Valeria R. Fantin, Cyrus V. Hedvat, Alexander E. Perl, Joshua D. Rabinowitz, Martin Carroll, Shinsan M. Su, Kim A. Sharp, Ross L. Levine, Craig B. Thompson, The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate Cancer Cell. ,vol. 17, pp. 225- 234 ,(2010) , 10.1016/J.CCR.2010.01.020